Advanced Research on Circulating Tumor Cells in Lung Cancer

Lung cancer is the malignant disease with the highest rate in terms of incidence and mortality in China. Early diagnosis and timely monitoring tumor recurrence and metastasis are extremely important for improving 5-year survival rate of lung cancer patients. Circulating tumor cells (CTCs), as a &quo...

Full description

Bibliographic Details
Main Authors: Hui LI, Hongxia CUI, Ying CHENG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2012-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2012.11.03
id doaj-4eb59fd697e448888ed6e58221521504
record_format Article
spelling doaj-4eb59fd697e448888ed6e582215215042020-11-25T00:53:06ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872012-11-01151166767110.3779/j.issn.1009-3419.2012.11.03Advanced Research on Circulating Tumor Cells in Lung CancerHui LIHongxia CUIYing CHENGLung cancer is the malignant disease with the highest rate in terms of incidence and mortality in China. Early diagnosis and timely monitoring tumor recurrence and metastasis are extremely important for improving 5-year survival rate of lung cancer patients. Circulating tumor cells (CTCs), as a "liquid biopsy specimens” for the primary tumor, provide the possibility to perform real-time, non-invasive histological identification for lung cancer patients. The detection of CTCs contributes to early diagnosis, surveillance of tumor recurrence and metastasis, and prediction of therapeutic efficacy and prognosis. Furthermore, CTCs-dependent detection emerges as a new approach for molecularly pathologic examination, study of molecular mechanisms involved in drug resistance, and resolution for tumor heterogeneity. This study reviewed the recent progress of CTCs in lung cancer research field.http://dx.doi.org/10.3779/j.issn.1009-3419.2012.11.03Lung neoplasmsCirculating tumor cellsTesting
collection DOAJ
language zho
format Article
sources DOAJ
author Hui LI
Hongxia CUI
Ying CHENG
spellingShingle Hui LI
Hongxia CUI
Ying CHENG
Advanced Research on Circulating Tumor Cells in Lung Cancer
Chinese Journal of Lung Cancer
Lung neoplasms
Circulating tumor cells
Testing
author_facet Hui LI
Hongxia CUI
Ying CHENG
author_sort Hui LI
title Advanced Research on Circulating Tumor Cells in Lung Cancer
title_short Advanced Research on Circulating Tumor Cells in Lung Cancer
title_full Advanced Research on Circulating Tumor Cells in Lung Cancer
title_fullStr Advanced Research on Circulating Tumor Cells in Lung Cancer
title_full_unstemmed Advanced Research on Circulating Tumor Cells in Lung Cancer
title_sort advanced research on circulating tumor cells in lung cancer
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
series Chinese Journal of Lung Cancer
issn 1009-3419
1999-6187
publishDate 2012-11-01
description Lung cancer is the malignant disease with the highest rate in terms of incidence and mortality in China. Early diagnosis and timely monitoring tumor recurrence and metastasis are extremely important for improving 5-year survival rate of lung cancer patients. Circulating tumor cells (CTCs), as a "liquid biopsy specimens” for the primary tumor, provide the possibility to perform real-time, non-invasive histological identification for lung cancer patients. The detection of CTCs contributes to early diagnosis, surveillance of tumor recurrence and metastasis, and prediction of therapeutic efficacy and prognosis. Furthermore, CTCs-dependent detection emerges as a new approach for molecularly pathologic examination, study of molecular mechanisms involved in drug resistance, and resolution for tumor heterogeneity. This study reviewed the recent progress of CTCs in lung cancer research field.
topic Lung neoplasms
Circulating tumor cells
Testing
url http://dx.doi.org/10.3779/j.issn.1009-3419.2012.11.03
work_keys_str_mv AT huili advancedresearchoncirculatingtumorcellsinlungcancer
AT hongxiacui advancedresearchoncirculatingtumorcellsinlungcancer
AT yingcheng advancedresearchoncirculatingtumorcellsinlungcancer
_version_ 1725239263852756992